Caught in the Complement Cascade: A Challenging Case of C1q Nephropathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0724; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He immigrated to the US and experienced relapses every 6-8 months requiring steroids, levamisole, and cyclophosphamide...Following the biopsy, he was started on tacrolimus and prednisone with improvement until January 2022...Case reports have supported use of rituximab, but regimens varied and patients were not followed longitudinally. Other non-immunologic approaches to reducing proteinuria have also been explored, including enalapril, SGLT2 inhibitors, and mineralocorticoid receptor antagonists."
Clinical • Glomerulonephritis • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Respiratory Diseases • Systemic Lupus Erythematosus
|
|
Alexander Otto Henze; Mohammed Ahnaf Arefin; Imran Amer; Swetha Rani Kanduri; Eric Ryan
|